Do direct oral anticoagulants (DOACs) effectively treat left ventricular thrombus without increasing stroke or bleeding complications compared to warfarin?
DOACs represent a viable, non-inferior alternative to warfarin for the treatment of left ventricular thrombus, with comparable safety and efficacy.
DOACs appears to be non-inferior or at least as effective as warfarin in the treatment of left ventricular thrombus without any statistical difference in stroke or bleeding complications.
Dalia et al. (Sun,) studied this question.